Literature DB >> 2439223

Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.

T Yamauchi, T A Raffin, P Yang, B I Sikic.   

Abstract

Oxygen is thought to be involved both directly and indirectly in the mechanisms of action of several anti-cancer agents. We studied the effects of various oxygen concentrations on the cytotoxicities of the following drugs: bleomycin (BLM), etoposide (VP-16), doxorubicin (DOX), and mitomycin C (MMC). Human sarcoma cells, MESSA, were exposed to drug for 1 h at one of several oxygen concentrations: less than 1%, 2.5%, 5%, 21%, and 95%. Cytotoxicity was assessed by cellular incorporation of 3H-thymidine into DNA 5 days after drug exposure. Control experiments varying oxygen concentration without drugs demonstrated toxicity only at the highest concentration (95%). Three different responses of drug sensitivity to varying oxygen tensions were observed. BLM, which has been shown to utilize oxygen as a substrate in generating free radicals and producing DNA scission, demonstrated a progressive increase in cytotoxicity over the entire range of increasing oxygen concentrations. This is consistent with the model of a BLM-cation-oxygen complex and catalytic reduction of oxygen. VP-16, which also produces DNA strand breakage but by interaction with topoisomerase II, exhibited a threshold response. VP-16 toxicity was ameliorated by anoxic conditions (less than 1% O2), but not by oxygen concentrations of 2.5%-95%. The reason for this protective effect of anoxia with VP-16 is not clear. In contrast, acute anoxia had no effect on the cytotoxicities of DOX and MMC. We conclude that acute hypoxia protects cells from both BLM and VP-16 but that the nature of that protection is different. VP-16 toxicity is blunted only by severe anoxia, whereas BLM exhibits a dose response effect over the entire range of oxygen concentrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439223     DOI: 10.1007/bf00261473

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  39 in total

1.  Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells.

Authors:  J D Loike; S B Horwitz
Journal:  Biochemistry       Date:  1976-12-14       Impact factor: 3.162

2.  Origin and cytotoxic properties of base propenals derived from DNA.

Authors:  A P Grollman; M Takeshita; K M Pillai; F Johnson
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

3.  The effect of hypoxia on the growth and radiation response of mammalian cells in culture.

Authors:  J S Bedford; J B Mitchell
Journal:  Br J Radiol       Date:  1974-10       Impact factor: 3.039

4.  Effects of adriamycin and X-rays on euoxic and hypoxic EMT-6 cells in vitro.

Authors:  J W Harris; D C Shrieve
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

5.  A new method of determining the fraction of hypoxic cells in a transplantable murine sarcoma.

Authors:  R P Hill; R S Bush
Journal:  Radiat Res       Date:  1977-04       Impact factor: 2.841

6.  A role for ferrous ion and oxygen in the degradation of DNA by bleomycin.

Authors:  E A Sausville; J Peisach; S B Horwitz
Journal:  Biochem Biophys Res Commun       Date:  1976-12-06       Impact factor: 3.575

7.  Structural studies of of "active complex" of bleomycin: assignment of ligands to the ferrous ion in a ferrous-bleomycin-carbon monoxide complex.

Authors:  N J Oppenheimer; L O Rodriguez; S M Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

Authors:  W Ross; T Rowe; B Glisson; J Yalowich; L Liu
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  Iron . bleomycin . DNA system evidence of a long-lived bleomycin . iron . oxygen intermediate.

Authors:  J P Albertini; A Garnier-Suillerot; L Tosi
Journal:  Biochem Biophys Res Commun       Date:  1982-01-29       Impact factor: 3.575

10.  Studies with bleomycin and misonidazole on aerated and hypoxic cells.

Authors:  L Roizin-Towle; E J Hall
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  2 in total

1.  Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.

Authors:  T K Li; L F Liu
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.

Authors:  Marie E Beckner; Wendy Fellows-Mayle; Zhe Zhang; Naomi R Agostino; Jeffrey A Kant; Billy W Day; Ian F Pollack
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.